Q. Ding

发表

Comparison of Drug Withdrawal Processes in the U.S. and Other Nations

A. Wertheimer, Hinal Patel, Hinal Patel, 2021, Innovations in pharmacy.

The Effect of the Unit Dose Dispensing System on Medication Preparation and Administration Errors in Intravenous (IV) Drugs in a Chinese Hospital: Inpatient

Q. Ding, 2012 .

Significant Reduction of Antibiotic Consumption and Patients’ Costs after an Action Plan in China, 2010–2014

Zhaoxin Lu, R. Peng, L. Bao, 2015, PloS one.

Predictors of biologic treatment of psoriasis: a non-interventional study

L. Puig, T. Fan, Q. Ding, 2014, ClinicoEconomics and outcomes research : CEOR.

The economic burden of biologic disease-modifying antirheumatic drugs in rheumatoid arthritis patients in the United States

Q. Ding, Alison M. Konieczny, D. Shiltz, 2022, Expert review of pharmacoeconomics & outcomes research.

A Multicenter Retrospective Analysis of Factors Associated With Apixaban-Related Bleeding in Hospitalized Patients With End-Stage Renal Disease on Hemodialysis

Taylor D. Steuber, Q. Ding, D. Shiltz, 2017 .

Burden of disease and patient-reported outcomes in patients with moderate to severe ulcerative colitis in the last 12 months - Multicenter European cohort study.

J. Gisbert, G. Van Assche, D. Gaya, 2016, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Treatment satisfaction, preferences and perception gaps between patients and physicians in the ulcerative colitis CARES study: A real world-based study.

J. Gisbert, G. Van Assche, D. Gaya, 2016, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Treatment persistence among patients with rheumatoid disease (RA, AS, PsA) treated with subcutaneous biologics in Germany

T. Fan, Jerrold W. Hill, S. Kachroo, 2015, Rheumatology International.

Persistence Rate With Subcutaneous Biologic Therapies in Patients With Ankylosing Spondylitis (As).

T. Fan, Q. Ding, M. Govoni, 2014, Value in Health.

Treatment persistence among patients with immune-mediated rheumatic disease newly treated with subcutaneous TNF-alpha inhibitors and costs associated with non-persistence

J. Dalén, A. Svedbom, S. Kachroo, 2016, Rheumatology International.

Getting Started in Clinical Pharmacy Research

A. Wertheimer, Q. Ding, 2016 .

Long-term outcomes of colectomy surgery among patients with ulcerative colitis

G. Kaplan, A. Hart, P. Gibson, 2015, SpringerPlus.

Persistence Rate With Subcutaneous Biologic Therapies in Patients With Rheumatoid Arthritis (Ra).

T. Fan, Q. Ding, M. Govoni, 2014, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.